It may soon be possible to identify Group 4 medulloblastomas—the most common malignant brain tumor in children—from more aggressive Group 3 tumors. Research based on a little-explored part of RNA, which creates proteins, ...
Sep 21, 2022
0
3
A study led by researchers at Boston Children's Hospital explains for the first time why COVID-19 causes severe inflammation in some people, leading to acute respiratory distress and multi-organ damage. Surprisingly, the ...
Apr 6, 2022
0
402
Separation and extraction of cell-free DNA (cfDNA) from biofluid samples is a difficult task due to the samples' short lengths and rarity. In a recent breakthrough, scientists from the Shibaura Institute of Technology, Japan, ...
Feb 4, 2022
0
2
Researchers have discovered a series of creativity-linked genes that may have given Homo sapiens a significant edge over Neanderthals, enabling them to avoid extinction.
Apr 23, 2021
0
228
More than a million people worldwide were diagnosed with stomach cancer in 2018, the fifth most prevalent cancer. The most common gastric tumor is gastric adenocarcinoma, originating in the gastric mucosa. A research team ...
Mar 18, 2021
0
3
Molecular markers in the blood shown to be predictive of severe COVID-19 outcomes resulting from SARS-CoV-2 coronavirus infection have been identified in a study by a Chinese research team. The study results extend understanding ...
Dec 14, 2020
0
2
Murdoch University's Australian National Phenome Center (ANPC) working with scientists at Imperial College London have developed a new integrative strategy for identifying biomarkers of health and disease.
Jul 20, 2020
0
124
Investigators at the Stanford University School of Medicine have pinpointed a molecular defect that seems almost universal among patients with Parkinson's disease and those at a high risk of acquiring it.
Sep 26, 2019
0
702
A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer. Based on these promising results ...
Jun 10, 2019
0
1
A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...
Mar 7, 2019
0
1
